US$ 26.63
glp 1 drug market GLP-1 Agonists Report 2025-2033, By Product, Molecule, and Geo GLP-1 Market Size, Share |
Description
Cognitive behavioral therapy (CBT) and interpersonal psychotherapy (IPT) remain first-line evidence-based treatments for BED, with robust data supporting their efficacy

and Novo Nordisk and has received support for attending meetings and/or travel from Eli Lilly & Co

Based at Bispebjerg Hospital, Holst was in an ideal location to address the question

Data were pooled for glucagon-like peptide 1 (GLP-1) receptor agonists and dipeptidyl-peptidase 4 (DPP-4) inhibitors in comparison with their respective controls and expressed as exposure-adjusted incidence rates

& Levien, T

There were no external funding sources for this study
